Document is current
Any future updates will be listed below
-
Authors
Sjöström, Martin http://orcid.org/0000-0002-2629-9966
Staaf, Johan
Edén, Patrik
Wärnberg, Fredrik
Bergh, Jonas
Malmström, Per
Fernö, Mårten
Niméus, Emma
Fredriksson, Irma
-
Funding
Funding for this research was provided by:
the Swedish Breast Cancer Association (BRO)
the Swedish Cancer Society (Cancerfonden)
Region Skåne
Governmental Funding of Research within the Swedish National Health Service (ALF)
Fru Berta Kamprads Stiftelse
Anna-Lisa and Sven-Erik Lundgren Foundation
Magnus Bergvalls Stiftelse
the Gunnar Nilsson Cancer Foundation
the Anna and Edwin Berger Foundation
the Swedish Cancer and Allergy Foundation
Skåne County Research Foundation (FOU)
Lund University Research Foundation
Skåne University Hospital Resarch Foundation
BioCARE
the King Gustaf V Jubilee Fund
The Cancer Society in Stockholm
the Marcus and Marianne Wallenberg Foundation
- License Information
-
More Information
Article History
Received: 15 January 2018
Accepted: 8 May 2018
First Online: 4 July 2018
Ethics approval and consent to participate
: This study was approved by the Ethics committee of Lund University (2010-127). Patients were informed of the study through advertisements, and further consent was waived by the ethics committee.
: Mårten Fernö and Per Malmström declare that they receive research funding and have royalty agreements with PFS Genomics. The other authors declare no potential conflicts of interest related to the present work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
